-- GlaxoSmithKline is considering a merger or share swap for its Indian consumer products division, in order to avoid a potential 40% tax burden on the sale of its Horlicks brand, reports The Economic Times, citing unnamed sources.

-- GSK could face a tax bill of at least $1.6 billion from a direct sale of the brand, according to The Economic Times.

 

Full story: https://bit.ly/2s4LMCW

 

Write to Barcelona editors at barcelonaeditors@dowjones.com

 

(END) Dow Jones Newswires

May 24, 2018 01:29 ET (05:29 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Gsk.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Gsk.